Digest Network Come funziona
Network
/
Società
Sp
Non verificato

Sparrow Pharmaceuticals

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
11/12/2024
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben
Fonte
Sparrow Pharmaceuticals
Emittente
Business Wire
1.00
0
14/11/2024
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Industria
Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth Cohort
Fonte
Sparrow Pharmaceuticals
Emittente
Business Wire
1.00
0
28/10/2024
Industria
Igiene alimentare
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Sparrow Pharmaceuticals Announces Completion of Phase 2 Trial and FDA Orphan Drug Designation of Clofutriben for Endogenous Cushing’s Syndrome
Fonte
Sparrow Pharmaceuticals
Emittente
Business Wire
1.00
0
19/09/2024
Eventi
Fiere
Industria
Farmaceutica
Salute
Medicina - Varie
Sparrow Pharmaceuticals Presented New Data on Clofutriben and Prednisolone for Polymyalgia Rheumatica Treatment at DGRh Kongress 2024
Fonte
Sparrow Pharmaceuticals
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0